Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 31,005

Document Document Title
WO/2017/068400A1
The present invention relates to a method for synthesising the compound (±)-ambroxide from the compound (±) 13,14,15,16-tetranor-8α,12-labdanodiol, the method comprising the steps of: a) dissolving the (±) 13,14,15,16-tetranor-8α,12...  
WO/2017/070012A1
Provided herein are compounds containing two redox centers including a chalcogen redox center of the formula: wherein: R1, R2, X1, X2, Y1, and m are as defined herein. Also provided herein are pharmaceutical composition of the present co...  
WO/2017/070084A1
The disclosed subject matter provides N- hydroxylsulfonamide derivative compounds of formulae (I), (II) or (III) as drawn below, pharmaceutical compositions comprising such compounds, kits comprising such compounds, and methods of using ...  
WO/2017/069210A1
Provided is an organic electroluminescent element that has, in order, an anode, a hole injection layer, a hole transport layer, a light emission layer, and a cathode, wherein the hole transport layer includes a compound represented by fo...  
WO/2017/069442A1
The present invention relates to a composition for an organic optoelectronic element, containing: at least one first compound represented by formula 1; and at least one second compound represented by formula 2, to an organic optoelectron...  
WO/2017/066103A1
A series of novel amides showing broad pharmaceutical activity. Compounds described herein are effective as anticonvulsants, chemical countermeasures, and analgesics. Such compounds also show, neuroprotective/neuroreparative effects and ...  
WO/2017/064512A1
Anti-angiogenic treatments, for example treatment of ocular neovascularization or cancer, treatments of hyperpermeability disorders, treatments of neuropathic and neurodegenerative disorders, pain treatments, methods of treating or preve...  
WO/2017/065980A1
Methods for preparing 1) a sugar-derived ester, 2) a glycol generated from reduction of the ester, and 3) polymers fabricated from polycondensation of the ester or glycol with various diamines and dicarboxylic acids are described. In par...  
WO/2017/064179A1
The present invention provides a process for the preparation of 1,4-butanediol and tetrahydrofuran said process comprising contacting furan with hydrogen and water in the presence of a supported catalytic composition comprising at least ...  
WO/2017/065415A1
The present invention relates to an organic light emitting diode capable of high efficiency- and low voltage-driving and having a reduced luminance reduction rate in a low grayscale area, and more specifically, to an organic light emitti...  
WO/2017/061788A1
The present specification relates to a spiro compound and an organic light-emitting device comprising same.  
WO/2017/061786A1
The present specification relates to a spiro compound and an organic light-emitting device comprising same.  
WO/2017/061865A1
Gamma-valerolactone (GVL) is prepared from a levulinic acid ester in a continuous process wherein a stream of the levulinic acid ester together with a gaseous stream of a hydrogen-containing gas is contacted with a hydrogenation catalyst...  
WO/2017/060922A4
The invention discloses aneco-friendly process for hydrogenation (alkenealkene, carbonyl compound and aromatic) and hydrodeoxygenation (methoxy phenols) of organic compound using hydrous ruthenium oxide (HRO) and its supported form as a ...  
WO/2017/060922A1
The invention discloses aneco-friendly process for hydrogenation (alkenealkene, carbonyl compound and aromatic) and hydrodeoxygenation (methoxy phenols) of organic compound using hydrous ruthenium oxide (HRO) and its supported form as a ...  
WO/2017/061785A1
The present specification relates to a spiro-type compound and an organic light emitting diode comprising same.  
WO/2017/061858A1
Process for the manufacture of an adipic acid product by a reduction of a tetrahydrofuran dicarboxylic acid compound, wherein the tetrahydrofuran dicarboxylic acid compound is contacted with hydrogen iodide at a temperature of at least 1...  
WO/2017/054524A1
Disclosed is a nematicide of trans structure containing a lactone ring, characterized in that the general structural formula I is as shown in (I). R1, R2, R3, R4 and R5 are selected from hydrogen, cyano, fluorine, chlorine, bromine, an a...  
WO/2017/058757A1
Uses of acyl-homoserine lactone compounds are described. In particular, uses of acyl-homoserine lactone compounds as anti-thrombotic agents, to inhibit platelets from becoming hypersensitive, and/or to prevent thrombosis, are described.  
WO/2017/058915A1
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, tautomer, stereoisomer or prodrug thereof, wherein A, B R1, R2a, R2b...  
WO/2017/059102A1
Provided herein, inter alia, are compositions and methods useful for treating hvperproliferative diseases, including cancer and non-malignant hvperproliferative diseases.  
WO/2017/057460A1
Provided is a method for producing an organic compound, wherein the organic compound is an industrially useful compound, and a deodorization step, for removing from a reaction solution odorants that are generated in or remaining after a ...  
WO/2017/054523A1
Disclosed are a nematicide containing a lactone ring, and a preparation method and a use thereof, where the nematicide comprises hydrogen, cyano, fluorine, chlorine, bromine, an alkyl containing 1 to 4 carbon atoms, an alkoxy containing ...  
WO/2017/059303A1
Provided herein are vinylogous thioester compounds and methods for using the compounds.  
WO/2017/057360A1
The present invention addresses the problem of providing: a polyimide which is derived from a novel tetracarboxylic dianhydride, has both excellent solubility in various types of organic solvents and thermoplasticity and therefore has ex...  
WO/2017/059318A3
The present disclosure relates to scaphopetalone analogs, methods of making the analogs, and their medicinal uses.  
WO/2017/059318A2
The present disclosure relates to scaphopetalone analogs, methods of making the analogs, and their medicinal uses.  
WO/2017/059347A1
Chewing gum base which include polymer material, such as polyvinyl acetate, and at least one miscible plasticizer are provided. The base can also include at least one emulsifier. The present application provides for methods of making gum...  
WO/2017/052129A1
The present invention provides an organic electric device comprising a hole transport layer and an electron blocking layer capable of improving the luminous efficiency, stability and lifetime of the organic electric device, and an electr...  
WO/2017/052099A1
Disclosed are a compound represented by chemical formula 1, an organic electronic device including a first electrode, a second electrode, and an organic material layer between a first electrode and a second electrode, and an electronic d...  
WO/2017/050609A1
A compound of formula (I) for use in electrolyte compositions for electrochemical cells.  
WO/2017/049409A1
Disclosed are compounds of general formula (I) that promote readthrough of a premature termination codon (PTC) of an RNA molecule in a translation system, and their use, alone or in combination with other compounds, such as aminoglycosid...  
WO/2017/051354A1
Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the p...  
WO/2017/045271A1
The present invention relates to the field of pharmaceutical chemistry, and specifically to a class of benzofuran derivatives (I). Pharmacodynamic tests prove that these compounds can be used for anti-tumor purposes and have a medical th...  
WO/2017/049211A1
Provided herein are methods of producing halomethylfuroic and acyloxymethylfuroic acid and ester compounds from furfural starting compounds. For example, 5-chloromethyl-2-furoic acid may be produced from 5-chloromethylfurfural, in the pr...  
WO/2017/049239A1
Provided herein are methods of producing polymers from furan and optionally diol compounds, using an organocatalyst. The furan compounds may include, for example, 2,5-furandicarboxylic acid or 2,5-tetrahydrofurandicarboxylic acid. Provid...  
WO/2017/048025A1
The present invention provides a novel compound capable of improving the luminous efficiency, stability, and life of an element, an organic electronic element using same, and an electronic device comprising same.  
WO/2017/046355A1
The invention relates to a method for the stereoselective preparation of compounds of formula (IV).  
WO/2017/048864A1
The present invention provides methods of making furfural fatty acids from (chloromethyl)furfural. The present invention also provides furfural fatty acids and nutritional supplements that include furfural fatty acids.  
WO/2017/047992A1
The present specification relates to a heterocyclic compound and an organic light emitting device comprising the same.  
WO/2017/042289A1
The present invention provides a process for the production of 1,4-BDO and THF from furan, said process comprising : (i) contacting furan with hydrogen and water in a reactor in the presence of a catalytic composition, wherein the furan ...  
WO/2017/043757A1
The present invention relates to an organic compound represented by chemical formula 1, an organic optoelectronic diode, and a display device.  
WO/2017/043835A1
The present invention provides: a compound capable of improving the high light emitting efficiency, the low driving voltage of a diode, and the lifespan of the diode; an organic electronic diode using the same; and a device therefor.  
WO/2017/041228A1
The present invention relates to the field of pharmaceutical synthesis, in particular to a method for preparing a hexahydrofurofuranol derivative, an intermediate thereof and a preparation method thereof. The preparation method uses a co...  
WO/2017/041139A1
The present invention relates to compounds and their uses, in particular, compounds in the form of prodrugs that promote transport of a pharmaceutical agent to the lymphatic system and subsequently enhance release of the parent drug.  
WO/2017/044957A1
The present invention relates to the synthesis of intermediate compounds which can be used in the synthesis of mint lactone and related compounds, including 3,6-dimethylhexahydrobenzofuran-2-ones, isomers, and other derivatives.  
WO/2017/043652A1
Provided are: an organic electroluminescent element containing, between a negative electrode and a positive electrode, a light-emitting layer that contains a compound represented by formula (1) and a compound represented by formula (11);...  
WO/2017/036574A1
The present application relates to a compound of a formula (I) or (II) where Ar1 is the same or different at each instance and is an aryl or heteroaryl group which has 6 to 18 aromatic ring atoms and may be substituted by one or more R1 ...  
WO/2017/035982A1
The present invention relates to the field of medicinal chemistry, and in particular, to diazonaphthoquinone compounds having antineoplastic activity and a preparation method for the compounds. The compounds can be activated by reduced c...  
WO/2017/040191A1
This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions con...  

Matches 51 - 100 out of 31,005